Imanishi-Kari's Appeal

The article "Decision In Imanishi-Kari Appeal Spurs Call For Changes In System" in your edition of August 19 [B. Goodman, The Scientist, page 1] reports that an appeals panel of the Department of Health and Human Services cleared Thereza Imanishi-Kari of all 19 counts of scientific misconduct. The panel consisted of two lawyers of the department and a Distinguished Service Professor from the University of Pittsburgh School of Medicine. The panelists could not deny that there are many things wr

Written byWalter Ehrlich
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The article "Decision In Imanishi-Kari Appeal Spurs Call For Changes In System" in your edition of August 19 [B. Goodman, The Scientist, page 1] reports that an appeals panel of the Department of Health and Human Services cleared Thereza Imanishi-Kari of all 19 counts of scientific misconduct. The panel consisted of two lawyers of the department and a Distinguished Service Professor from the University of Pittsburgh School of Medicine.

The panelists could not deny that there are many things wrong with the paper in question; however, they qualified all the wrongs as mere errors. We cannot judge because the errors are not spelled out in the article, save one: We can learn that the data used in the paper are different from those that were recorded and from those written in the protocol. This is, however, not qualified as misconduct but is explained by the "innocent" fact that "Dr. Imanishi-Kari ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies